Navigation Links
Dendreon Reports Third Quarter 2010 Financial Results
Date:11/3/2010

eptember 30, 2010 was $347.6 million, or $2.54 per share, which includes a non-cash charge associated with the revaluation of warrants of $142.6 million or $1.04 per share, compared to $187.7 million, or $1.79 per share for the nine months ended September 30, 2009, which included a non-cash charge of $122.8 million or $1.17 per share for warrant revaluation.

As of September 30, 2010, Dendreon had $392.7 million in cash, cash equivalents, and short-term and long-term investments compared to $606.4 million as of December 31, 2009.

Highlights include:

  • Since approval Dendreon has received over 1,000 prescriptions for PROVENGE.
  • Dendreon is on track to make PROVENGE more broadly available in 2011 with the expansion and anticipated licensure of its New Jersey facility in early 2011 and its facilities in Atlanta, Georgia and Orange County, California in mid-2011, for which construction is substantially complete.
  • Dendreon’s revenue guidance for full year 2010 is approximately $46-47 million and for 2011 is expected to be in the range of $350-400 million, with approximately half of that expected to be generated in Q4, based on a standard FDA review period and approval of our new manufacturing facilities.
  • PROVENGE data were presented at the Asian Congress of Urology, European Society of Medical Oncology, and the International Society for Biological Therapy of Cancer.

  • Conference Call InformationDendreon will host a conference call today at 1:30 p.m. PT, 4:30 p.m. ET. To access the live call, dial 1-866-730-5769 (domestic) or +1-857-350-1593 (international); the conference pass code is 35737817. The call will also be audio webcast and will be available from the Company's website at www.dendreon.com under the "Investor/Webcasts and Presentations" section. A recorded rebroadcast will be available for interested parties unable to participate in the live conference call b
    '/>"/>

    SOURCE Dendreon Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Dendreon Announces Presentation of PROVENGE Data at the 25th International Society for Biological Therapy of Cancer Annual Meeting
    2. Dendreon Statement on CMS National Coverage Analysis
    3. Dendreon Announces Presentation of PROVENGE Data at the American Urological Association Annual Meeting
    4. Dendreon Presents Updated IMPACT Results Confirming PROVENGE Improves Overall Survival in Patients With Metastatic Castrate-Resistant Prostate Cancer
    5. Dendreon Reports Fourth Quarter and 2009 Year End Financial Results
    6. Dendreon Announces Election of Ian Clark and Pedro Granadillo to Board of Directors
    7. Dendreon Reports PROVENGE Regulatory and Commercialization Progress and Future Pipeline Plans at Analyst Event
    8. Dendreon Presents Preclinical Data Demonstrating Activity of TRPM8 Agonist, D-3263, in Benign Prostatic Hyperplasia
    9. Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
    10. Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial
    11. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)...  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced the ... Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) ... in order to treat dental impairments, for tooth restoration ...
    (Date:1/15/2014)... AARP Foundation today announced it has established a ... severe cold weather that has gripped much of the nation. ... need; so to support these emergency relief efforts AARP and ... could mean up to $500,000 in aid. The matching program ...
    (Date:1/15/2014)...  Celsion Corporation (the "Company") (NASDAQ: CLSN ) ... investors to purchase an aggregate of approximately $15 million ... direct offering, led by a dedicated health care fund. ... with these investors pursuant to which the Company agreed ...
    Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3
    (Date:7/9/2014)... A retrospective study conducted by researchers at Tufts ... among adults with intellectual and developmental disabilities, the likelihood ... receiving dental care increased. The findings, published in the ... may help improve interventions designed to address the oral ... researchers reviewed the dental records of 107 patients at ...
    (Date:7/9/2014)... , , , , , ... , , , , ... assault rifle and the microphone is 50m downrange from the firer and approximately 30cm from the bullet... , ... , , , , , ... , , , , , , ...
    (Date:7/9/2014)... microbiologists from the Keck School of Medicine of ... that mice lacking a specific component of the ... potentially fatal complication of infection. The discovery suggests ... reduce inflammation in human autoimmune and hyper-inflammatory diseases ... , The study was published online on June ...
    (Date:7/8/2014)... LIVERMORE, Calif. The Department of Defense,s Defense ... National Laboratory (LLNL) up to $2.5 million to ... to record and stimulate neurons within the brain ... week. , The research builds on the understanding ... in certain regions of the brain encode information, ...
    (Date:7/8/2014)... 8, 2014 In a study published yesterday in ... the La Jolla Institute (LJI) led by Pandurangan Vijayanand, Ph.D. ... that currently affects over 200 million people world wide. ... can be divided into small sections or ,neighborhoods., Scientists ... or primed for gene production, by looking for a marker ...
    Breaking Medicine News(10 mins):Health News:Adults with special needs see gains, challenges with long term oral care 2Health News:Adults with special needs see gains, challenges with long term oral care 3Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 2Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 3Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 4Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 5Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 6Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 7Health News:DARPA selects Lawrence Livermore to develop world's first neural device to restore memory 2Health News:DARPA selects Lawrence Livermore to develop world's first neural device to restore memory 3Health News:LJI develops new approach to identify genes poised to respond in asthma patients 2
    ... Mother,s Day Walk to Empower and Makes Donation for ... No One Faces Breast Cancer AlonePHILADELPHIA, May 7 ... America, which markets bladder control products and services under ... known as Serenity(R)), is teaming up with ...
    ... in China face considerable economic hardship following stroke, and it ... below the poverty line. The large study shows over 70% ... their financial situation due to loss of income and cost ... and Chinese researcher,s and published in Stroke ...
    ... comprehensive new teaching aid, the FRAX Slide-kit, has ... in cooperation with the World Health Organization Collaborating ... UK. The educational slides can be downloaded free ... http://www.iofbonehealth.org/health-professionals/frax.html , The FRAX Slide-kit is ...
    ... Halls of Congress This Week to Advocate for Additional Resource ... 7 This Friday, ... Health Awareness Day, an extension of National Mental Health Month. ... Attention-Deficit/Hyperactivity Disorder (CHADD) and the American Academy of Child & ...
    ... is National Lupus Awareness MonthWASHINGTON, May 7 ... risks associated with breast cancer and heart disease, but ... aware of another potentially fatal disease that disproportionately strikes ... The disease is lupus.Although more than 1.5 million ...
    ... Savings, Compliance and Protection of Patient Information Drives ... Decho Corporation, an EMC Company (NYSE: ... organizations using its industry-leading MozyPro(R) online backup solution ... in the past year. Mozy(TM) is the ...
    Cached Medicine News:Health News:Breast Cancer Network of Strength(R) and SCA Personal Care North America, Through Its TENA(R) Brand, Team Up to Offer Support to Women Affected by Breast Cancer 2Health News:Breast Cancer Network of Strength(R) and SCA Personal Care North America, Through Its TENA(R) Brand, Team Up to Offer Support to Women Affected by Breast Cancer 3Health News:Breast Cancer Network of Strength(R) and SCA Personal Care North America, Through Its TENA(R) Brand, Team Up to Offer Support to Women Affected by Breast Cancer 4Health News:New study reveals the financial effects of stroke in China 2Health News:The New Face of AD/HD Comes to Capitol Hill 2Health News:Public Lacks Awareness of Serious Disease With Life-Threatening Complications 2Health News:Public Lacks Awareness of Serious Disease With Life-Threatening Complications 3Health News:Decho Doubles Number of Mozy Healthcare Customers 2Health News:Decho Doubles Number of Mozy Healthcare Customers 3
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    Medicine Products: